CXCR6 expressing T cells: Functions and role in the control of tumors.
CAR T cell
CXCL16
CXCR6
dendritic cell
immunotherapy
mucosal vaccination
resident memory T cell
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
08
2022
accepted:
27
09
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
2
11
2022
Statut:
epublish
Résumé
CXCR6 is a receptor for the chemokine CXCL16, which exists as a membrane or soluble form. CXCR6 is a marker for resident memory T (T
Identifiants
pubmed: 36311728
doi: 10.3389/fimmu.2022.1022136
pmc: PMC9597613
doi:
Substances chimiques
Receptors, CXCR6
0
Chemokine CXCL16
0
Cxcr6 protein, mouse
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1022136Informations de copyright
Copyright © 2022 Mabrouk, Tran, Sam, Pourmir, Gruel, Granier, Pineau, Gey, Kobold, Fabre and Tartour.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Am J Respir Crit Care Med. 2005 Nov 15;172(10):1290-8
pubmed: 16100013
J Immunother Cancer. 2018 Sep 4;6(1):87
pubmed: 30180905
Gut. 2011 Nov;60(11):1494-505
pubmed: 21471570
Nat Immunol. 2000 Oct;1(4):298-304
pubmed: 11017100
J Biol Chem. 2000 Dec 29;275(52):40663-6
pubmed: 11060282
J Infect Dis. 2014 Nov 1;210(9):1508-16
pubmed: 24823625
Nat Immunol. 2017 Aug;18(8):940-950
pubmed: 28628092
Nat Biomed Eng. 2021 Nov;5(11):1246-1260
pubmed: 34083764
Front Immunol. 2022 Feb 01;13:819224
pubmed: 35178050
Cell. 2021 Aug 19;184(17):4512-4530.e22
pubmed: 34343496
Cancer Sci. 2008 Jul;99(7):1362-9
pubmed: 18452560
Mediators Inflamm. 2015;2015:368427
pubmed: 26494947
Science. 2018 May 25;360(6391):
pubmed: 29798856
J Immunol. 2000 Sep 15;165(6):3284-92
pubmed: 10975845
Nature. 2021 Apr;592(7854):444-449
pubmed: 33762736
Mol Carcinog. 2019 Oct;58(10):1886-1896
pubmed: 31270884
J Clin Invest. 2017 Aug 1;127(8):2930-2940
pubmed: 28650338
J Immunol Res. 2021 Mar 27;2021:6660379
pubmed: 33855090
Nature. 1997 Jul 17;388(6639):238
pubmed: 9230431
Cancer. 2019 Jun 1;125(11):1941-1942
pubmed: 30748000
Cancer Res. 2008 Dec 15;68(24):10367-76
pubmed: 19074906
Cell Rep. 2017 Sep 19;20(12):2921-2934
pubmed: 28930685
Trends Mol Med. 2012 Dec;18(12):742-9
pubmed: 23083809
Cancer Res. 1999 Aug 1;59(15):3698-704
pubmed: 10446984
PLoS Biol. 2005 Apr;3(4):e113
pubmed: 15799695
Front Immunol. 2020 Aug 07;11:1773
pubmed: 32849637
PLoS One. 2014 May 15;9(5):e97701
pubmed: 24832098
Immunity. 2019 Dec 17;51(6):1043-1058.e4
pubmed: 31810882
J Exp Med. 2019 Dec 2;216(12):2736-2747
pubmed: 31558614
Science. 2016 Apr 22;352(6284):459-63
pubmed: 27102484
Front Immunol. 2019 May 27;10:1018
pubmed: 31191515
J Immunol. 2009 Nov 1;183(9):5807-15
pubmed: 19812206
J Immunol. 2001 Apr 15;166(8):5145-54
pubmed: 11290797
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34
pubmed: 15701862
J Exp Med. 2002 Apr 1;195(7):869-79
pubmed: 11927631
J Immunol. 2003 Aug 15;171(4):1647-51
pubmed: 12902461
Nat Commun. 2017 May 24;8:15221
pubmed: 28537262
Int J Mol Sci. 2019 Nov 18;20(22):
pubmed: 31752131
Life Sci Alliance. 2021 Aug 6;4(10):
pubmed: 34362825
J Virol. 2008 Jul;82(14):6812-9
pubmed: 18480435
PLoS One. 2017 Mar 7;12(3):e0173486
pubmed: 28267793
Nat Immunol. 2016 Dec;17(12):1467-1478
pubmed: 27776108
Immunity. 2019 Dec 17;51(6):1028-1042.e4
pubmed: 31810883
Sci Rep. 2019 Feb 21;9(1):2527
pubmed: 30792527
J Exp Med. 2021 Jan 4;218(1):
pubmed: 33601412
Cancer Cell. 2021 Feb 8;39(2):193-208.e10
pubmed: 33357452
Sci Transl Med. 2013 Feb 13;5(172):172ra20
pubmed: 23408053
Nature. 2021 Apr;592(7854):450-456
pubmed: 33762733
Cancer Sci. 2020 Apr;111(4):1254-1265
pubmed: 32012403
Immunity. 2020 Aug 18;53(2):335-352.e8
pubmed: 32610077
Gastroenterology. 2019 May;156(6):1877-1889.e4
pubmed: 30710528
Radiat Res. 2010 Apr;173(4):418-25
pubmed: 20334513
J Neuroimmunol. 2013 Jul 15;260(1-2):47-54
pubmed: 23628207
Sci Rep. 2019 Sep 16;9(1):13288
pubmed: 31527616
Science. 2018 Oct 12;362(6411):
pubmed: 30309915
J Immunol. 2006 Dec 1;177(11):7833-40
pubmed: 17114454
Immunobiology. 2008;213(7):599-608
pubmed: 18656707
PLoS One. 2009 Aug 19;4(8):e6695
pubmed: 19690611
Nat Med. 2018 Jul;24(7):978-985
pubmed: 29942094
J Leukoc Biol. 2005 May;77(5):777-86
pubmed: 15703197
J Immunother Cancer. 2021 Mar;9(3):
pubmed: 33692218
Front Immunol. 2021 Feb 23;12:595722
pubmed: 33708198
J Immunol. 2017 Oct 1;199(7):2451-2459
pubmed: 28855310
Acta Pharm Sin B. 2022 Aug;12(8):3255-3262
pubmed: 35967287
PLoS One. 2014 Jun 04;9(6):e99056
pubmed: 24897301
Cell Rep. 2021 May 11;35(6):109118
pubmed: 33979626
Cells. 2021 Dec 22;11(1):
pubmed: 35011579
Cell Rep. 2018 Feb 20;22(8):2107-2117
pubmed: 29466737
Front Immunol. 2018 Jul 27;9:1722
pubmed: 30100906
N Engl J Med. 2022 Jun 2;386(22):2112-2119
pubmed: 35648703
Cell. 2020 Aug 6;182(3):655-671.e22
pubmed: 32603654
J Exp Med. 2017 Jun 5;214(6):1567-1580
pubmed: 28526759
Blood. 2002 Mar 15;99(6):2114-21
pubmed: 11877287
J Immunol. 2008 Sep 1;181(5):3099-107
pubmed: 18713980
Toxins (Basel). 2022 Mar 10;14(3):
pubmed: 35324699
Immunology. 2007 Aug;121(4):555-64
pubmed: 17437534
Nat Cancer. 2022 May;3(5):581-594
pubmed: 35314826
Cancer Res. 2012 Jul 15;72(14):3546-56
pubmed: 22710437
J Immunol. 2008 Jul 1;181(1):81-91
pubmed: 18566372
Tumour Biol. 2015 Nov;36(11):8811-8
pubmed: 26058873
Immunity. 2019 May 21;50(5):1317-1334.e10
pubmed: 30979687
J Immunol. 2005 Jan 15;174(2):1055-62
pubmed: 15634930
PLoS One. 2013 Jun 19;8(6):e65488
pubmed: 23840334
Infect Immun. 2011 Aug;79(8):3328-37
pubmed: 21628524
J Immunother Cancer. 2021 Oct;9(10):
pubmed: 34607898
J Exp Med. 2019 Dec 2;216(12):2748-2762
pubmed: 31558615
J Immunother Cancer. 2021 Aug;9(8):
pubmed: 34462326